1. Home
  2. LAB vs AIP Comparison

LAB vs AIP Comparison

Compare LAB & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • AIP
  • Stock Information
  • Founded
  • LAB 1999
  • AIP 2003
  • Country
  • LAB United States
  • AIP United States
  • Employees
  • LAB N/A
  • AIP N/A
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • AIP Semiconductors
  • Sector
  • LAB Industrials
  • AIP Technology
  • Exchange
  • LAB Nasdaq
  • AIP Nasdaq
  • Market Cap
  • LAB 504.2M
  • AIP 579.6M
  • IPO Year
  • LAB 2011
  • AIP 2021
  • Fundamental
  • Price
  • LAB $1.24
  • AIP $13.09
  • Analyst Decision
  • LAB Buy
  • AIP Strong Buy
  • Analyst Count
  • LAB 2
  • AIP 3
  • Target Price
  • LAB $2.50
  • AIP $15.00
  • AVG Volume (30 Days)
  • LAB 1.6M
  • AIP 696.1K
  • Earning Date
  • LAB 11-04-2025
  • AIP 11-04-2025
  • Dividend Yield
  • LAB N/A
  • AIP N/A
  • EPS Growth
  • LAB N/A
  • AIP N/A
  • EPS
  • LAB N/A
  • AIP N/A
  • Revenue
  • LAB $172,271,000.00
  • AIP $63,236,000.00
  • Revenue This Year
  • LAB N/A
  • AIP $19.05
  • Revenue Next Year
  • LAB N/A
  • AIP $17.96
  • P/E Ratio
  • LAB N/A
  • AIP N/A
  • Revenue Growth
  • LAB 76.33
  • AIP 18.64
  • 52 Week Low
  • LAB $0.92
  • AIP $5.46
  • 52 Week High
  • LAB $2.32
  • AIP $14.88
  • Technical
  • Relative Strength Index (RSI)
  • LAB 45.85
  • AIP 52.49
  • Support Level
  • LAB $1.12
  • AIP $13.23
  • Resistance Level
  • LAB $1.25
  • AIP $13.91
  • Average True Range (ATR)
  • LAB 0.09
  • AIP 0.92
  • MACD
  • LAB -0.01
  • AIP -0.18
  • Stochastic Oscillator
  • LAB 34.29
  • AIP 29.25

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About AIP Arteris Inc.

Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

Share on Social Networks: